James Nunley, DO
Pain Medicine · Manchester, TNNPI 1144227067
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Boston Scientific at 40.5% of the total. That places this record below the midpoint for pain medicine clinicians in TN, where the typical reported total is $2,322.
Across 156 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$939
- Scilex Pharmaceuticals Inc.$365
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$196
- Collegium Pharmaceutical, Inc.$196
- Relievant Medsystems, Inc.$139
- Curonix LLC$65
- plus $421 from 13 others
What the payments were for
- Food & beverage$2,322100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 79 | $939 |
| Scilex Pharmaceuticals Inc. | 22 | $365 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $196 |
| Collegium Pharmaceutical, Inc. | 12 | $196 |
| Relievant Medsystems, Inc. | 6 | $139 |
| Curonix LLC | 3 | $65 |
| AbbVie | 3 | $59 |
| Amgen | 2 | $43 |
| Arbor Pharmaceuticals, Inc. | 3 | $42 |
| Vertiflex, Inc. | 1 | $36 |
| Nalu Medical, Inc. | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 2 | $33 |
| Almatica Pharma LLC | 2 | $32 |
| Pacira Therapeutics, Inc. | 2 | $32 |
| Flowonix Medical Incorporated | 1 | $32 |
| Sentynl Therapeutics, Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Bioventus LLC | 1 | $16 |
How this compares
$2,322 in reported general payments places this provider in the 50th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 14 | $4,587 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 33 | $3,766 |
| Oxycodone Hcl | 85 | $2,095 |
| Fentanyl | 13 | $1,594 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $1,537 |
| Gabapentin | 88 | $1,214 |
| Diclofenac Sodium | 11 | $619 |
| Pregabalin | 23 | $378 |
| Methadone Hcl | 20 | $369 |
| Tizanidine Hcl | 50 | $355 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $351 |
| Tramadol Hcl | 40 | $217 |
| Duloxetine Hcl | 13 | $146 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $125 |
| Zolpidem Tartrate | 13 | $110 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Manchester
- Jason HerndonManchester$6K
- Shravani DurbhakulaNashville$353K
- Joseph DichiaraKnoxville$102K
- Stephanie VanterpoolKnoxville$69K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
- Puneet MishraNashville$32K
- John BlakeChattanooga$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.